SCHEMBL13289052

SCHEMBL13289052

Bc1cnn2c(NCc3ccc(CNS(=O)(=O)c4ccc(C)cc4)cc3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 6/20 0.53
▸ GSK3B P49841 5/20 0.49
▸ CYP1A2 P05177 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ NAMPT P43490 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289053 0.93 CDK2 (0.53) CDK2GSK3BCYP1A2CYP3A4ALDH1A1
SCHEMBL14545999 0.92 CDK2 (0.54) CDK2GSK3BCYP1A2CYP3A4LMNA
SCHEMBL14546000 0.92 CDK2 (0.53) CDK2GSK3BCYP1A2CYP3A4CA9
SCHEMBL13288936 0.90 CDK2 (0.50) CDK2GSK3BCYP1A2CYP3A4ALDH1A1
SCHEMBL13120668 0.90 CDK2 (0.67) CDK2GSK3BCYP1A2CYP3A4CA12
SCHEMBL13289272 0.89 GSK3B (0.48) CDK2GSK3BCYP1A2CYP3A4LMNA
SCHEMBL12954278 0.88 CDK2 (0.52) CDK2GSK3BCYP1A2CYP3A4ALDH1A1
SCHEMBL13289431 0.88 CDK2 (0.49) CDK2GSK3BCYP1A2CYP3A4MEN1
SCHEMBL13289029 0.87 GSK3B (0.47) CDK2GSK3BCYP1A2CYP3A4LMNA
SCHEMBL13288973 0.87 CDK2 (0.48) CDK2GSK3BCYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback